7.6 HIV Testing, Initial Assessment and Care

Key Takeaways

  • Interpret an HIV test using its window period and exposure context. Suspected acute HIV warrants timely clinical and laboratory assessment.

  • After confirmation, arrange specialist care. HIV RNA follows viral suppression and the CD4 count helps assess immune compromise.

  • Escalate suspected active opportunistic infection and support prevention, treatment engagement, confidential partner care and public health notification.

Last updated: November 2026

Match the test to the exposure and timing

Take a confidential history of the type and date of possible exposure, prior tests, HIV pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), current medicines and symptoms. Discuss testing and how results will be shared. A fever, rash, pharyngitis or lymphadenopathy in the weeks after a plausible exposure may reflect acute HIV. The same symptoms can occur with other illnesses. Many people with HIV have no symptoms for a prolonged period, so offer testing according to exposure and clinical indications even if the patient feels well. The ECDC/EACS testing standard also recommends offering testing when an HIV indicator condition is present or suspected. Assess whether testing for other STIs, hepatitis B and C or TB is indicated by the presentation and exposure history.

FindingNext decision
Recent exposure in the Irish PEP windowSeek urgent PEP assessment. Baseline testing is useful and should not delay indicated prophylaxis.
Negative rapid or self-test taken earlyCheck the assay, elapsed time and any PrEP or PEP. The HSE patient guidance cites usual window periods of about six weeks for clinic blood testing and 12 weeks for rapid or self-testing. Use the actual assay and specialist plan for repeat testing.
Recent exposure with possible seroconversionArrange prompt clinic assessment and a laboratory combined HIV antigen/antibody test. Discuss with the HIV service or virology laboratory whether further tests or earlier repeat testing are appropriate. An early negative result can occur during infection.
Reactive rapid or self-testArrange confirmatory laboratory testing. Explain that a screening reaction needs confirmation and ensure the person can access the result and follow-up.

A clinician should seek prompt specialist advice if test results disagree or acute HIV remains likely. The Irish National Virus Reference Laboratory identifies combined antigen/antibody assays as the screening approach. Its manual cautions against routine RNA testing in antibody-negative people because low-level nonspecific results can occur. The Irish PrEP guidance considers RNA testing in selected people with a significant concern for recent acquisition and defers PrEP where there are features of seroconversion until HIV is excluded. These are different clinical settings.

HSE HIV testing · ECDC/EACS testing standard · HSE HIV symptoms · HSE HIV prevention · Irish PrEP clinical guidance · UCD National Virus Reference Laboratory manual.

Test Your Knowledge

A 26-year-old had condomless sex with a new partner three weeks ago and now has fever, sore throat and a widespread rash. A self-test taken two weeks after the exposure was negative. There has been no subsequent exposure and the person is clinically stable. What is the best HIV-related next step?

A

Explain that the self-test excluded HIV and investigate only other infections

B

Arrange prompt clinical assessment and laboratory antigen/antibody testing, with a plan for additional or repeat testing based on specialist advice

C

Start the standard 28-day course of PEP for the exposure three weeks ago

D

Start PrEP today using the prior self-test as sufficient evidence

Confirm the diagnosis and establish what care is urgent

Link a person with confirmed HIV to an Irish specialist service, usually through infectious diseases or sexual health. Explain that antiretroviral therapy (ART) is offered regardless of CD4 count and usually starts promptly after diagnosis. The team considers previous PrEP, PEP or ART, treatment interactions, pregnancy and clinical illness. A serious opportunistic infection such as cryptococcal or tuberculous meningitis can change the timing of ART and needs specialist coordination.

Plasma HIV RNA measures viraemia and is the principal marker for following viral suppression. The CD4 count reflects cellular immune status and contributes to decisions about opportunistic infection prophylaxis and testing. Baseline assessment also includes resistance testing, kidney and liver function, hepatitis B and C screening and relevant tests for other co-infections. With a concurrent illness, stabilise and investigate in parallel. A low CD4 count is a risk marker. It cannot identify the pathogen.

Worked decision. Advanced untreated HIV with progressive breathlessness, dry cough and low oxygen saturation raises concern for Pneumocystis jirovecii pneumonia (PJP). Give urgent hospital care and assess oxygenation and severity. Consider bacterial pneumonia, TB and other causes, with appropriate infection-control precautions where indicated. The team can obtain respiratory samples and decide on early treatment when suspicion is high. Prophylaxis alone is inadequate for a suspected active infection.

In follow-up, use non-judgmental counselling and address barriers to taking treatment. A person with sustained undetectable HIV viral load on effective ART does not transmit HIV sexually (U=U). Continue monitoring, and discuss protection against other STIs as appropriate. Offer support for confidential partner notification and testing. Explain statutory notification to Public Health under the Irish infectious diseases rules. It is handled through confidential channels and serves a different purpose from offering help to inform partners.

HSE HIV treatment · ECDC/EACS standard on starting ART · HSE living with HIV · HSE monitoring and U=U · NIH baseline evaluation · NIH Pneumocystis guidance · WHO ART timing in people with HIV · HPSC HIV notification · HPSC notification procedure.

Test Your Knowledge

A 39-year-old who has recently received a confirmed HIV diagnosis and has not yet started ART presents with two weeks of worsening dry cough and breathlessness. The CD4 count is 68 cells/µL, oxygen saturation is 89% on room air and chest imaging shows bilateral interstitial changes. What is the best initial plan?

A

Arrange routine HIV follow-up because these findings are expected before starting ART

B

Give Pneumocystis prophylaxis and review in one month

C

Arrange urgent hospital care and assess for active Pneumocystis pneumonia and other causes of hypoxaemia

D

Repeat the HIV antibody test before evaluating the respiratory symptoms

Sections you finish are checked off in the contents.